menu
    • menu

    Company profile for Biostar Stem Cell Technology Research Institute

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biostar Stem Cell Technology Research Institute has the most advanced equipment for cell cultivation. It boasts production capacity of 30,000 cases or above, one of the highest in the world. Biostar Stem Cell Technology Research Institute complies with the GMP Facility Standards, the most widely followed standard for pharmaceutical production facilities, to ensure safe production. a leading stem cell firm of Korea, specializes...
    Biostar Stem Cell Technology Research Institute has the most advanced equipment for cell cultivation. It boasts production capacity of 30,000 cases or above, one of the highest in the world. Biostar Stem Cell Technology Research Institute complies with the GMP Facility Standards, the most widely followed standard for pharmaceutical production facilities, to ensure safe production. a leading stem cell firm of Korea, specializes in research and development of therapeutic agents for diseases with damaged cells and incurable diseases and in providing stem cell banking service for future treatment of diseases using.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biostar Stem Cell Technology Research Institutekorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    08506 305, Lotte IT Castle Building #2, 550-1, Gasan-dong, Geumcheon-gu, Seoul...
    Telephone
    Telephone
    +82-2-874-0686
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.stemcellbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biostar Advances Stem Cell Therapy for Autism
    Biostar Advances Stem Cell Therapy for Autism

    08 Aug 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/biostar-advances-stem-cell-therapy-for-autism-offering-new-possibilities-for-families-1057890

    ACCESSWIRE
    08 Aug 2025
    Share Share
    FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Trial
    FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Trial

    15 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approved-utidelone-injectable-utd1-phase-23-multi-national-clinical-trial-for-non-small-cell-lung-cancer-301851826.html

    PR NEWSWIRE
    15 Jun 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search